Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
Researchers conducted a population-based cohort study involving patients with T2D aged 18 years and older initiating treatment with SGLT-2i or metformin.
Heart Failure Information Center
ACC Issues Expert Guidance for Cardiovascular Sequelae After SARS-CoV-2 Infection
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
Metformin and Improved Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.
Recommendations Updated for Management of Heart Failure
Sodium-glucose cotransporter-2 inhibitors recommended for HF with reduced, mildly reduced ejection fraction.
Trends in Health-Related Quality of Life Among Patients With Advanced Heart Failure
Researchers compared heart transplant candidates and patients considering mechanical circulatory support to determine differences in health-related quality of life.
Jardiance Approved for Heart Failure Independent of LVEF
The approval was based on data from the phase 3 EMPEROR-Preserved trial.
Aspirin Use Tied to Incident Heart Failure in At-Risk Adults
Aspirin use was associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
Heart Attack + COVID-19 Significantly Ups In-Hospital Mortality
Findings for both out-of-hospital and in-hospital ST-segment elevation myocardial infarction.
World Heart Day: 5 Ways Your Patients Can Reduce Cardiovascular Disease Risk
It has been estimated that cardiovascular disease (CVD) claims 18.6 million lives per year. As World Heart Day seeks to raise awareness on CVD prevention and management, what are some ways your patients can reduce their risk?
Echocardiographic Phenotypes Predict Long-Term Outcomes in Asymptomatic HF
Echocardiographic phenotypes significantly improved the prognostic performance on top of the ARIC HF risk score, and discriminative values were “consistently observed on top of traditionally defined cardiac structure or function abnormalities.”
Risk Factors for MACE After First Acute Coronary Syndrome Identified
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Does Hemodynamic-Guided Management of Heart Failure Improve Outcomes?
This study evaluated the effects of hemodynamic-guided management of heart failure on composite mortality and heart failure events.
Heart Failure in Patients With COVID-19
The authors describe how to diagnose and treat patients with heart failure who develop COVID-19 disease in this case study.
Empagliflozin Benefits Patients With Heart Failure and Preserved Ejection Fraction
The phase 3 EMPEROR-Preserved trial assessed empagliflozin in 5988 adults with heart failure with preserved ejection fraction, with and without diabetes.
Early Rhythm Control Beneficial in Patients With AF and Heart Failure
Researchers determined the effects of early rhythm control therapy in patients diagnosed with atrial fibrillation with signs and symptoms of heart failure.
40% of Incident Heart Failure Diagnoses Occur in Acute Care
46 percent of those diagnosed in acute care had potential heart failure symptoms in previous six months.
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Methamphetamine-Linked Heart Failure Up in California
Increase of 585 percent seen in methamphetamine-associated cardiomyopathy/heart failure hospitalizations from 2008 to 2018
Heart Failure Linked to Increased Incidence of Cancer
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs
AHA Releases Scientific Statement on Sleep-Disordered Breathing and Cardiovascular Disease
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Heart Failure Information Center
Loading... 
Loading...